Phaarmasia Limited (BOM:523620)
112.00
+4.76 (4.44%)
At close: Apr 16, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 764.62 million as of April 16, 2026. Its market cap has increased by 165.40% in one year.
Market Cap
764.62M
Enterprise Value
760.32M
Revenue
449.06M
Ranking
n/a
PE Ratio
4.31
Stock Price
112.00
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 764.62M, an increase of 5,480.27%. That is a compound annual growth rate of 15.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 732.12M | -4.88% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 924.00M |
| Makers Laboratories | 919.28M |
| Accretion Pharmaceuticals | 824.25M |
| Source Natural Foods and Herbal Supplements | 796.25M |
| Godavari Drugs | 756.29M |
| Asston Pharmaceuticals | 749.14M |
| Amwill Health Care | 727.33M |
| Onyx Biotec | 683.58M |